Mohammad Razvi

Mohammad Razvi MD, PMP, is a seasoned professional in clinical operations and development, currently serving as Director at Boston Immune Technologies and Therapeutics, with a focus on first-in-human oncology trials. Razvi brings extensive experience from roles at MD Clinical Research LLC as Principal, overseeing clinical research consulting and contracting. Prior positions include Associate Director at Boehringer Ingelheim, where responsibilities spanned clinical trial management and vendor oversight, as well as Clinical Operations Manager at AbbVie, managing multiple studies and ensuring compliance with timelines and budgets. Razvi's career also includes significant contributions at organizations like PPD, and Vanderbilt University Medical Center, where clinical research and oncological studies were primary areas of focus. Razvi holds an MBBS degree from Karachi University.